financetom
Market
financetom
/
Market
/
Why Yes Bank plunged 12% after financial fraud emerged at CG Power
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Yes Bank plunged 12% after financial fraud emerged at CG Power
Aug 21, 2019 2:24 AM

Shares of Yes Bank fell 5 percent, hitting its 52-week low of Rs 67.55 per share on Wednesday, extending Tuesday's losses amid concerns over its exposure to CG Power, which has been hit by alleged financial irregularities and unauthorised transactions. The stock has fallen nearly 12 percent since yesterday after the allegations against CG Power surfaced.

Share Market Live

NSE

Yes Bank has 12.79 percent stake in CG Power. In May, the private sector lender acquired a stake in the company on the invocation of pledged shares of its promoter.

"While working on one of its priority tasks of seeking refinancing of certain facilities and as a part of conducting financial analysis in this regard, the Operations Committee was made aware of some unauthorised transactions by certain employees of the company," said CG Power in a BSE filing.

The board also found that the total liabilities of the company and the group may have been potentially understated. “The total liabilities of the company and the group may have been potentially understated by approximately Rs 1053.54 crore and Rs 1,608.17 crore respectively as at 31 March 2018; and by Rs 601.83 crore and Rs 401.83 crore respectively as at 1 April 2017,“ the filing added.

CG Power said that certain assets of the company were purportedly provided as collateral without due authority, and the company was made a co-borrower and/or guarantor for enabling ostensibly unrelated third parties to obtain loans without due authorisation.

At 9:59 AM, the stock was trading 2.5 percent lower at Rs 69.45 per share on the BSE as compared to 0.03 percent (10 points) rise in Sensex at 37,338. Meanwhile, CG Power hit its lower circuit, down 20 percent for the second straight session.

Also, track all live market action on CNBC-TV18 Market Blog

Disclaimer: CNBCTV18.com advises users to check with certified experts before taking any investment decisions

First Published:Aug 21, 2019 11:24 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall Street set for mixed open as markets assess earnings, await data
US STOCKS-Wall Street set for mixed open as markets assess earnings, await data
May 25, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Futures: Dow up 0.30%, S&P 500 down 0.13%, Nasdaq off 0.23% * Honeywell gains after rise in Q1 profit * General Motors ( GM ) pulls forecast on tariff uncertainty * Consumer confidence, JOLTS data due on the day...
Economic Data Loom as US Equity Futures Turn Mixed Pre-Bell
Economic Data Loom as US Equity Futures Turn Mixed Pre-Bell
May 25, 2025
08:11 AM EDT, 04/29/2025 (MT Newswires) -- US equity futures were mixed pre-bell Tuesday as traders eyed a string of economic data. Dow Jones Industrial Average futures gained 0.4%, S&P 500 futures slipped 0.1%, and Nasdaq futures were down 0.2%. Investors are also looking ahead to earnings from Microsoft ( MSFT ) , Meta Platforms ( META ) , Apple...
Regeneron Pharma's first-quarter results miss on lower Eylea demand
Regeneron Pharma's first-quarter results miss on lower Eylea demand
May 25, 2025
(Reuters) -Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye disease drug Eylea, sending the company's shares tumbling 7% in premarket trading. The drugmaker has been grappling with stiff competition for Eylea from cheaper versions and rivals, including Roche's Vabysmo. Regeneron said Eylea sales were also hit by lower wholesale inventory...
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
May 25, 2025
08:18 AM EDT, 04/29/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was slightly up by 0.03% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% lower in Tuesday's premarket activity as investors await key economic data to be released later in the day, and access a mix of pharmaceutical and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved